Karoo Health
Karoo Health Raises $16.2M Series A for AI-Native Cardiovascular Platform
Karoo Health announced $16.2M in Series A financing on July 21, 2026. Karoo Health raised a $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures to develop its AI-native cardiovascular platform.
Round details
The financing includes backing from 7wire Ventures, Allumia Ventures, First Trust Capital Partners, SpringRock Ventures, Hyde Park Angels. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $16.2M
How the company plans to use the capital
Karoo said it will use the proceeds to further develop its AI-native cardiovascular platform, expand its engineering and clinical teams, and scale deployments with payer and provider partners.
Why this matters for GTM teams
Karoo says its platform connects clinical, claims, pharmacy, and patient data, and that it supports a network of more than 600 cardiology providers across 11 states.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Karoo Health Series A announcement.
Company Info
Investors (5)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started